The timing is perfect to bring in a quality company like Arrowroot that can provide usage of the resources we need to gasoline our continued development.’ ‘We are thrilled to partner with MedNet during its following stage of growth,’ stated Matthew Safaii, Handling Partner of Arrowroot Capital. ‘Rob Robertson and his group have constructed a nimble, highly configurable and robust SaaS platform. The iMedNet EDC option has demonstrated incredible traction among CROs and sponsors supporting clinical trials of most types and sizes. We're looking towards rolling up our sleeves and supporting MedNet grow to its whole potential.’.. Arrowroot Capital makes $4 million purchase in MedNet Solutions MedNet Solutions, a global life sciences technology firm specializing in clinical study management systems, is pleased to announce that Arrowroot Capital, a rise equity firm focused on software-as-a-assistance and Internet-based businesses, has made a $4 million expense in MedNet Solutions.‘Both Cancer Research UK and CRT are world leaders in discovering, commercialising and developing a cancer treatments, that there remains a high unmet need, and through their network have the ability to access excellent study. The EIF is consequently delighted to end up being partnering with CRT which investment right now becomes the largest technology transfer operation partnered by EIF to-time. It illustrates EIF’s commitment to supporting advancement and research in Europe.’ Minister for Science and Universities, David Willetts, said: ‘In our Strategy for UK Lifestyle Sciences we set out ambitious plans to build on the success of the sector by fostering collaboration between our superb research base and businesses.